Clinical Study | Open Access
Hala El-Mesallamy, Salwa Suwailem, Nadia Hamdy, "Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus Patients", Mediators of Inflammation, vol. 2007, Article ID 073635, 7 pages, 2007. https://doi.org/10.1155/2007/73635
Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus Patients
This study compared lipids, the product of lipid peroxidation malondialdehyde (MDA), the acute phase reactant high sensitive C-reactive protein (hsCRP), endothelin-1 (ET-1), -selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) between healthy controls, subjects with ischemic heart disease (IHD) and type 2 diabetes mellitus (DM) subjects who did not perform coronary artery bypass graft (CABG) surgery as well as type 2 DM subjects who performed CABG. , lipids, MDA, hsCRP, ET-1, -selectin, ICAM-1, and VCAM-1 levels were significantly higher in the diabetic groups than in either healthy controls or IHD subjects. In the diabetic groups, there was a negative association among hsCRP and HDL-C. ET-1, ICAM-1 levels and TAG were positively correlated, as do the association between -selectin, VCAM-1 and . Also a positive relation was found among hsCRP levels and ICAM-1, as well as MDA and ET-1. -selectin and ICAM-1 were significantly positively correlated. This study indicates that increased level of oxidative stress marker, proinflammatory markers and their downstream effectors adhesion molecules occurs in type 2 DM.
- O. I. Stenina, “Regulation of vascular genes by glucose,” Current Pharmaceutical Design, vol. 11, no. 18, pp. 2367–2381, 2005.
- R. C. A. Tostes and M. N. Muscará, “Endothelin receptor antagonists: another potential alternative for cardiovascular diseases,” Current Drug Targets - Cardiovascular and Haematological Disorders, vol. 5, no. 4, pp. 287–301, 2005.
- P. A. Insel, S. Kornfeld, P. W. Majerus et al., “Blasts from the past,” Journal of Clinical Investigation, vol. 114, no. 8, pp. 1017–1033, 2004.
- M. Meydani, “Soluble adhesion molecules: surrogate markers of cardiovascular disease?” Nutrition Reviews, vol. 61, no. 2, pp. 63–68, 2003.
- G. Davì, A. Falco, and C. Patrono, “Lipid peroxidation in diabetes mellitus,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 256–268, 2005.
- A. Ergul, J. S. Johansen, C. Strømhaug et al., “Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 1, pp. 70–77, 2005.
- E. C. Abraham, T. A. Huff, N. D. Cope, J. B. Wilson Jr., E. D. Bransome Jr., and T. H. Huisman, “Determination of the glycosylated hemoglobins (Hb ) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus,” Diabetes, vol. 27, no. 9, pp. 931–937, 1978.
- P. Trinder, “Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen,” Journal of Clinical Pathology, vol. 22, no. 2, pp. 158–161, 1969.
- W. Richmond, “Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum,” Clinical Chemistry, vol. 19, no. 12, pp. 1350–1356, 1973.
- J. Siedel, E. O. Hagele, J. Ziegenhorn, and A. W. Wahlefeld, “Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency,” Clinical Chemistry, vol. 29, no. 6, pp. 1075–1080, 1983.
- M. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970.
- W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972.
- J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001.
- D. R. Janero, “Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury,” Free Radical Biology and Medicine, vol. 9, no. 6, pp. 515–540, 1990.
- D. G. Waller, A. G. Renwick, and K. Hillier, “Ischaemic heart disease,” in Medical Pharmacology and Therapeutics, p. 81, W. B. Saunders, Philadelphia, Pa, USA, 2001, chapter 5.
- C. Vitale, M. Fini, F. Leonardo et al., “Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease,” Maturitas, vol. 40, no. 3, pp. 239–245, 2001.
- K. Matsumoto, Y. Sera, Y. Abe et al., “High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus,” Metabolism, vol. 51, no. 7, pp. 932–934, 2002.
- N. Kaul, S. Devaraj, and I. Jialal, “-tocopherol and atherosclerosis,” Proceedings of the Society for Experimental Biology and Medicine, vol. 226, no. 1, pp. 5–12, 2001.
- F. O. Pereira, T. S. Frode, and Y. S. Medeiros, “Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus,” Mediators of Inflammation, vol. 2006, Article ID 39062, p. 7, 2006.
- M. B. Schulze, E. B. Rimm, T. Li, N. Rifai, M. J. Stampfer, and F. B. Hu, “C-reactive protein and incident cardiovascular events among men with diabetes,” Diabetes Care, vol. 27, no. 4, pp. 889–894, 2004.
- A. Saitta, D. Altavilla, D. Cucinotta et al., “Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 9, pp. 1512–1519, 2001.
- E. Ercan, H. Bozdemir, I. Tengiz et al., “Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris,” Thrombosis Journal, vol. 2, no. 1, pp. 4–9, 2004.
- L. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini, “Atherosclerosis and Lipoproteins: elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 4, pp. 656–661, 2002.
- T. Kerner, O. Ahlers, H. Reschreiter, C. Bührer, M. Möckel, and H. Gerlach, “Adhesion molecules in different treatments of acute myocardial infarction,” Critical Care, vol. 5, no. 3, pp. 145–150, 2001.
- N. Zimmermann, A. Wenk, U. Kim et al., “Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery,” Circulation, vol. 108, no. 5, pp. 542–547, 2003.
- I. Kowalska, M. Straczkowski, M. Szelachowska et al., “Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism,” Metabolism, vol. 51, no. 6, pp. 733–736, 2002.
Copyright © 2007 Hala El-Mesallamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.